基于时间顺序的心肾综合征对主要结局的长期影响:一项法国全国性综合队列研究
该法国全国性回顾性队列研究纳入2012年住院的385 687例慢性肾脏病(CKD)或心力衰竭(HF)患者,评估5年调整后主要结局风险。心肾综合征(CRS)患者死亡、心血管死亡和HF风险较单纯CKD或HF明显升高,其中心肾型CRS表型最差;CKD与HF对主要临床结局无协同作用。
要点
- CRS患者5年死亡发生率为79.2%,高于单纯CKD的57.3%和单纯HF的53.0%。
- 心肾型CRS是预后最差的表型,其死亡、心血管死亡和HF风险增加最明显。
- 与单纯CKD相比,仅心肾型CRS的终末期肾病风险相似,肾心型和同时型CRS风险轻度增加。
核心结论
- CRS相较单纯HF或CKD对长期肾脏和心血管风险的额外影响高度异质,取决于所考虑的事件和CRS时间顺序。
- 未能证明HF与CKD对主要临床结局存在协同作用。
研究设计与样本
- 法国全国性回顾性队列研究,纳入2012年入住法国医院的5 123 193例患者中所有385 687例CKD或HF患者。
- 评估5年调整后主要结局风险,按CRS时间顺序(同时型、心肾型、肾心型)分组分析。
主要发现
- 整体中84.0%患者为HF,8.9%为CKD(两者年龄、性别比、糖尿病和高血压患病率相似),7.1%为CRS(中心肾型44.6%、肾心型14.5%、同时型40.8%)。
- 单纯CKD、单纯HF和CRS的5年死亡发生率分别为57.3%、53.0%、79.2%;心血管死亡分别为18.8%、10.9%、27.5%;HF分别为52.6%、34.7%、64.3%。
- 单纯CKD、单纯HF和CRS的5年心肌梗死发生率分别为6.2%、5.5%、5.6%;缺血性卒中分别为6.1%、5.8%、5.3%;终末期肾病分别为23.1%、4.8%、16.1%。
- 与单纯CKD或HF相比,CRS患者死亡、心血管死亡和HF风险明显增加,其中心肾型CRS表型最差。
- CRS亚型相关的心肌梗死和缺血性卒中风险增加有统计学意义但无临床意义;与单纯CKD相比,仅心肾型CRS的终末期肾病风险相似,肾心型和同时型CRS风险轻度增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiorenal syndromes (CRSs) are reputed to result in worse prognosis than isolated heart failure (HF) and chronic kidney disease (CKD). Whether it is true for all major outcomes over the long-term regardless of CRS chronology (simultaneous, cardiorenal and renocardiac CRS) is unknown. METHODS: The 5-year adjusted risk of major outcomes was assessed in this nationwide retrospective cohort study in all 385 687 with either CKD or HF (out of 5 123 193 patients who were admitted in a French hospital in 2012). RESULTS: Overall, 84.0% patients had HF and 8.9% had CKD (they had similar age, sex ratio, diabetes and hypertension prevalence), while 7.1% had CRS (cardiorenal: 44.6%, renocardiac: 14.5%, simultaneous CRS: 40.8%).The incidence of major outcomes was 57.3%, 53.0%, 79.2% for death; 18.8%, 10.9%, 27.5% for cardiovascular death; 52.6%, 34.7%, 64.3% for HF; 6.2%, 5.5%, 5.6% for myocardial infarction (MI); 6.1%, 5.8%, 5.3% for ischaemic stroke; and 23.1%, 4.8%, 16.1% for end-stage kidney disease (ESKD) for isolated CKD, isolated HF and CRS, respectively.As compared with isolated CKD or HF, the risk of death, cardiovascular death and HF was markedly increased in CRS, the worse phenotype being cardiorenal CRS, while the increased risk of MI and ischaemic stroke associated with CRS subtypes was statistically but not clinically significant. As compared with isolated CKD, the risk of ESKD was similar for cardiorenal CRS only and marginally increased for renocardiac and simultaneous CRS. We could not find a synergy between HF and CKD on major clinical outcomes in the whole population (n = 5 123 193 patients). CONCLUSIONS: The additional impact of CRS versus isolated HF or CKD on long-term kidney and cardiovascular risk is highly heterogenous, depending of the event considered and CRS chronology. No synergy between HF and CKD could be demonstrated.
引用
- Halimi JM, de Fréminville JB, Gatault P, et al. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study. Nephrol Dial Transplant. 2022. PMID: 35438794. doi:10.1093/ndt/gfac153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。